Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E14.68 EPS (ttm)3.25 Insider Own- Shs Outstand2.40B Perf Week1.45%
Market Cap114.69B Forward P/E13.51 EPS next Y3.53 Insider Trans- Shs Float2.42B Perf Month-3.38%
Income7.93B PEG3.97 EPS next Q- Inst Own11.20% Short Float0.42% Perf Quarter-12.35%
Sales41.41B P/S2.77 EPS this Y22.40% Inst Trans5.15% Short Ratio3.32 Perf Half Y-12.19%
Book/sh4.28 P/B11.14 EPS next Y7.13% ROA16.70% Target Price55.67 Perf Year-3.28%
Cash/sh2.26 P/C21.11 EPS next 5Y3.70% ROE105.20% 52W Range46.01 - 55.21 Perf YTD-7.16%
Dividend2.56 P/FCF135.13 EPS past 5Y4.60% ROI24.90% 52W High-13.60% Beta0.60
Dividend %5.37% Quick Ratio0.80 Sales past 5Y1.70% Gross Margin68.90% 52W Low3.67% ATR0.63
Employees99451 Current Ratio1.10 Sales Q/Q-16.00% Oper. Margin24.90% RSI (14)42.24 Volatility0.92% 1.03%
OptionableYes Debt/Eq2.88 EPS Q/Q-37.50% Profit Margin27.50% Rel Volume1.32 Prev Close47.81
ShortableYes LT Debt/Eq2.37 EarningsFeb 03 Payout69.50% Avg Volume3.08M Price47.70
Recom2.60 SMA200.62% SMA50-6.07% SMA200-7.81% Volume4,035,500 Change-0.23%
08-Aug-14Reiterated Argus Buy $65 → $55
23-Apr-14Upgrade Argus Hold → Buy
28-May-13Upgrade Deutsche Bank Hold → Buy
11-Jan-11Upgrade Jefferies Hold → Buy
02-Jun-10Upgrade Jefferies Hold → Buy
16-Feb-10Upgrade JP Morgan Underweight → Neutral $26
13-Jan-10Downgrade Credit Suisse Outperform → Underperform
24-Nov-09Initiated Leerink Swann Mkt Perform
16-Nov-09Initiated Deutsche Securities Hold
12-Nov-09Initiated Barclays Capital Equal Weight
23-Oct-09Downgrade Jefferies & Co Buy → Hold
17-Mar-09Initiated Credit Suisse Outperform
26-Jan-09Initiated Jefferies & Co Buy
14-Nov-08Downgrade UBS Buy → Neutral
18-Apr-08Downgrade JP Morgan Neutral → Underweight
11-Feb-08Upgrade UBS Neutral → Buy
01-Feb-08Upgrade HSBC Securities Underweight → Neutral
24-Oct-07Initiated Bernstein Mkt Perform
06-Sep-07Initiated UBS Neutral
25-Jul-07Downgrade Bear Stearns Peer Perform → Underperform
21-Aug-14 04:05PM  GlaxoSmithKline's (GSK) Arnuity Ellipta Approved by FDA Zacks
07:49AM  The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International Zacks
20-Aug-14 03:33PM  GSK receives FDA approval for Arnuity Ellipta┬« (fluticasone furoate) in the US for the treatment of asthma PR Newswire
03:01PM  Why Mylan (MYL) Stock Is Advancing Today at TheStreet
06:01AM  Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win at TheStreet
19-Aug-14 10:11AM  The Warren Buffett Guide to Making Money Yahoo Finance Blogs
18-Aug-14 09:09AM  As The Ebola Outbreak Expands, These Experimental Drugs Could See Action at Forbes
09:09AM  As Ebola Outbreak Expands, These Experimental Drugs Could See Action at Forbes
12-Aug-14 03:56PM  [$$] Glaxo's Chief Faces Rising Pressure at The Wall Street Journal
12:37PM  [$$] Glaxo's Chief Faces Rising Pressure at The Wall Street Journal
09:50AM  Moving Average Crossover Alert: GlaxoSmithKline (GSK) Zacks
09:49AM  How Will GlaxoSmithKline (GSK) Stock React To Multiple Pressures Facing The Drug Maker? at TheStreet
12:17AM  [$$] Glaxo's Chief Faces Rising Pressure at The Wall Street Journal
11-Aug-14 10:51PM  [$$] Glaxo's Chief Faces Rising Pressure at The Wall Street Journal
09:24PM  [$$] Glaxo's Chief Faces Rising Pressure at The Wall Street Journal
05:30PM  [video] Biotechs race for Ebola cure at CNBC
05:15PM  [$$] Glaxo Chief Faces Rising Pressure at The Wall Street Journal
01:30PM  How Will GlaxoSmithKilne (GSK) Stock Respond To New Drug Bribery Allegations In Syria? at TheStreet
09:56AM  [video] U.S. Markets Start Week Higher On Easing Geopolitical Tensions at TheStreet
09:09AM  Priceline's outlook disappoints; Kinder Morgan unites; MannKind shares rocket Hot Stock Minute
07:59AM  Amazon picks a new fight; The bulls are back; Debate over experimental Ebola drugs Hot Stock Minute
07:59AM  Amazon picks a new fight; The bulls are back; Debate over experimental ebola drugs Hot Stock Minute
07:59AM  Amazon picks a new fight; China increases pressure on foreign companies; Debate over experimental Ebola drugs Hot Stock Minute
06:58AM  Super Moon illusion or buy the dips on this stock market? at MarketWatch
08-Aug-14 04:10PM  Dynavax Technologies Q2 Loss Wider than Expected, Sales Beat Zacks
11:58AM  In China, British Investigator Hired by Glaxo, and Wife, Sentenced to Prison at New York Times
11:58AM  In China, British Investigator Hired by Glaxo, and His Wife, Are Sentenced to Prison at New York Times
11:58AM  In China, British Investigator Hired by Glaxo and His Wife Are Sentenced to Prison at New York Times
08:10AM  Theravance (THRX) Incurs Narrower-than-Expected Loss in Q2 Zacks
06:43AM  [video] Glaxo trial begins in China at CNBC
05-Aug-14 05:22PM  Drugmaker AstraZeneca Returns To Growth at Investor's Business Daily
04:24PM  Glaxos Advair Win Undermined by Lack of Coverage on Breo Drug at Bloomberg
09:00AM  GSK's COPD.com Relaunch Promotes Understanding and Dialogue about COPD PR Newswire
06:45AM  Chinese Regulators Search Daimler Offices at New York Times
06:45AM  Chinese Regulators Search Daimler Offices at New York Times
04-Aug-14 07:01PM  Novo Nordisk Leapfrogs Glaxo as U.K. Drug Giant Declines at Bloomberg
04:18PM  Stock Market Today: Risky Complacency Brings Stocks Higher TheStreet
03:39PM  Stock Market Today: Risky Complacency Brings Stocks Higher TheStreet
11:03AM  Why GlaxoSmithKline (GSK) Stock Is Higher Today at TheStreet
03-Aug-14 11:04AM  Rising China's Hidden Edge: 'Flexible' Law Enforcement at Forbes
01-Aug-14 08:47AM  GlaxoSmithKline LLC -- Moody's downgrades GlaxoSmithKline to A2, outlook stable at Moody's
31-Jul-14 11:35AM  [video] Catalent Pharma Solutions CEO Talks IPO, Potential Biotech Bubble at TheStreet
30-Jul-14 06:00PM  Why There's Far More To Pfizer Than Viagra at Investopedia
05:20AM  AstraZeneca to Pay Up to $2.1 Billion For Respiratory Drugs at New York Times
05:20AM  AstraZeneca to Pay Almirall Up to $2.1 Billion for Respiratory Drugs at New York Times
29-Jul-14 03:31PM  GSK's Tanzeum is now available in pharmacies in the U.S. PR Newswire
08:21AM  What You Were Buying Last Week: GlaxoSmithKline plc at Motley Fool
28-Jul-14 10:53PM  [$$] Investigators Tied to GSK Get Trial Date at The Wall Street Journal
05:30PM  Novartis Division Gets European Approval for Simbrinza Zacks
11:33AM  Will GlaxoSmithKline plc Split Itself In Two? at Motley Fool
09:47AM  Glaxo Has No Plans to Spin Off Consumer Health-Care Division at Bloomberg
08:47AM  Why GlaxoSmithKline (GSK) Stock Is Higher Today at TheStreet
03:43AM  The FTSE 100's Hottest Dividend Picks: GlaxoSmithKline plc at Motley Fool
25-Jul-14 12:57PM  3 Shares That Can Benefit From A Resurgent UK Economy at Motley Fool
11:18AM  Baksheesh? Glaxo Allegedly Paid Bribes in Syria, too, a Report Says at The Wall Street Journal
09:54AM  Today's Top Health Care Headlines: AbbVie and GlaxoSmithKline at Motley Fool
08:18AM  Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
07:50AM  The Buy Case For GlaxoSmithKline plc Is Getting Stronger Every Day at Motley Fool
07:47AM  Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
06:58AM  Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
06:47AM  Don't Panic, Dividends Are Doing Fine at Motley Fool
04:38AM  Glaxo Investigates Allegations of Bribery in Syria at Bloomberg
12:01AM  Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
24-Jul-14 11:02PM  Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
10:55PM  UCB's Brivaracetam Positive in Phase III Epilepsy Study Zacks
09:07PM  Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
06:57PM  GlaxoSmithKline Investor's Business Daily
06:13PM  Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
05:29PM  [$$] Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
04:40PM  Can GlaxoSmithKlines Slumping Stock Recover? at Wall St. Cheat Sheet
04:32PM  Were There Any Silver Linings in GlaxoSmithKline Stock's Earnings Failure? at Motley Fool
02:05PM  3 Game-Changing Stories That Shook Investors: Inovio Pharmaceuticals, Gilead Sciences, and GlaxoSmithKline at Motley Fool
01:32PM  FDA Approves Flonase┬« Allergy Relief For Sale Over-The-Counter In The United States PR Newswire
01:11PM  [$$] Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
12:15PM  [$$] Glaxo Files Its Entry in Race for a Malaria Vaccine at The Wall Street Journal
10:20AM  Glaxo (GSK) Slips on Disappointing Q2 Earnings, Cuts View Zacks
09:00AM  3 Positives From This Week's GlaxoSmithKline plc Results at Motley Fool
07:55AM  Glaxo Seeks Approval for Worlds First Malaria Vaccine at Bloomberg
06:54AM  GlaxoSmithKline Slumps: GSK Falls 5.9% in Session Zacks
04:11AM  Is GlaxoSmithKline plc A Safe Dividend Investment? at Motley Fool
12:25AM  [$$] GlaxoSmithKline Reduces Full-Year Earnings Forecast at The Wall Street Journal
23-Jul-14 10:40PM  [$$] GlaxoSmithKline Reduces Full-Year Earnings Forecast at The Wall Street Journal -5.98%
09:00PM  Glaxosmithkline Reports Weak Sales and Cuts Outlook at New York Times
09:00PM  Glaxosmithkline Reports Weak Sales and Cuts Outlook at New York Times
08:51PM  [$$] GlaxoSmithKline Reduces Full-Year Earnings Forecast at The Wall Street Journal
08:05PM  Jim Cramer's 'Mad Money' Recap: Unconventional Wisdom at TheStreet
07:35PM  Jim Cramer's 'Mad Money' Recap: Unconventional Wisdom at TheStreet
07:01PM  Glaxos Witty Has Bigger Problem Than China as Sales Sag at Bloomberg
04:19PM  Is Inovio Undervalued After Positive HPV Therapy Results? at Seeking Alpha
01:08PM  China Bribery Probe, Dismal Advair Sales Leave Glaxo Shares Gasping at Forbes
12:56PM  Why GlaxoSmithKline (GSK) Stock Continues To Sink Today at TheStreet
12:32PM  [video] GlaxoSmithKline Cuts Full-Year Outlook as Weak Advair Sales Weigh at TheStreet
11:58AM  Glaxo slides in London after earnings warning at MarketWatch
11:37AM  [$$] Glaxo Reduces Earnings Forecast at The Wall Street Journal
11:31AM  [$$] U.S. Takes Wind Out of Glaxo's Sales at The Wall Street Journal
11:31AM  Europe closes higher despite Ukraine tensions at CNBC
10:30AM  Should You Buy GlaxoSmithKline plc Or AstraZeneca plc? at Motley Fool
10:13AM  Europe up despite Ukraine tensions; GSK slumps at CNBC
10:01AM  Glaxo shares fall in London after earnings warning at MarketWatch
09:55AM  Europe up amid Ukraine tensions; AkzoNobel bounces at CNBC
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company provides pharmaceutical products in various therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also offers consumer health products in total wellness, oral care, nutritional, and skin health areas. The company's total wellness products comprise Panadol for the treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; and ENO Tums, a rapid relief antacid. Its oral care products include Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. The company's nutrition products comprise Horlicks and Maxinutrition for nutrition; and skin health products include Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. In addition, it provides prescription medicines; and paediatric and adult vaccines against various infectious diseases. The company has a strategic cancer immunotherapy collaboration with Adaptimmune Limited to develop and commercialize NY-ESO-1 clinical cancer program. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerAug 11Buy3912271.66172,651675,457,614,37130,748,723Aug 11 04:55 PM
GLAXOSMITHKLINE PLC10% OwnerMay 09Buy8544835.30317,7702,715,292,313,28130,576,072May 13 04:43 PM
GLAXOSMITHKLINE PLC10% OwnerApr 01Buy12.00103,7621,245,1441,989,598Apr 02 12:42 PM
GLAXOSMITHKLINE PLCFormer 10% OwnerFeb 19Buy14.0035,000490,0001,356,533Feb 20 06:56 PM
GLAXOSMITHKLINE PLC10% OwnerFeb 11Buy12850698.95342,2294,397,881,850,96030,258,302Feb 13 04:41 PM
GLAXOSMITHKLINE PLCFormer 10% ShareholderFeb 10Buy12.00143,7731,725,276143,773Feb 12 05:56 PM
GLAXOSMITHKLINE PLC10% OwnerOct 29Buy4913613.18130,473641,093,852,43429,916,073Oct 29 05:37 PM